Sunshine Biopharma, Inc. (NASDAQ:SBFMW) Short Interest Down 85.7% in August

Sunshine Biopharma, Inc. (NASDAQ:SBFMW) was the recipient of a large decrease in short interest in August. As of August 14th, there was short interest totaling 773 shares, a decrease of 85.7% from the July 30th total of 5,398 shares. Based on an average daily volume of 190 shares, the days-to-cover ratio is currently 4.1 days.

Sunshine Biopharma Trading Down 0.5%

SBFMW stock traded down $0.00 during midday trading on Friday, reaching $0.04. 1,650 shares of the company’s stock traded hands, compared to its average volume of 14,443. Sunshine Biopharma has a fifty-two week low of $0.02 and a fifty-two week high of $0.65. The business has a 50-day moving average price of $0.04 and a two-hundred day moving average price of $0.09.

About Sunshine Biopharma

Sunshine Biopharma is a development-stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics for oncology and antiviral applications. The company’s research activities encompass the design, synthesis and preclinical evaluation of compounds that inhibit key pathways involved in cell proliferation and viral replication.

Among its lead programs, Sunshine Biopharma is advancing Adva-27a, a topoisomerase II inhibitor licensed from the National Research Council of Canada, which is undergoing preclinical studies for potential use in breast and ovarian cancers.